Statistics for NervGen Pharma Corp (id:1295 NGEN)
Valuation metrics
Market cap
185.61M
Enterprise value
120.27M
Trailing P/E (ttm)
-8.18
Forward P/E
-6.29
PEG ratio
-6.29
Price/Sales (ttm)
Price/Book (mrq)
23.74
Enterprise Value/Revenue
Enterprise Value/EBITDA
-6.25
Overview
Shares outstanding
70.31M
Float
58.21M
Shares short
199.54K
% Held by insiders
3.00%
% Held by institutions
5.00%
Average volume (10 days)
39.61K
Average volume (90 days)
Price summary
52-Week low
1.65
52-Week high
3.98
52-Week change
12.54%
Beta
1.35
50-Day moving average
2.51
200-Day moving average
2.53
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-53.14%
Return on equity
-230.27%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-19,244,188.00
Net income to common (ttm)
-23,082,324.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
26.56M
Total cash per share (mrq)
3.00
Total debt (mrq)
152.08K
Total Debt/Equity (mrq)
1.22
Current ratio (mrq)
178.20%
Book value per share (mrq)
5.00
Cash flow
Cash flow statement
-11,943,389.00
Levered free cash flow (LFCF)
-866,688.00